These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30205654)

  • 1. Benzimidazole - Schiff bases and their complexes: synthesis, anticancer activity and molecular modeling as Aurora kinase inhibitor.
    Magd-El-Din AA; Mousa HA; Labib AA; Hassan AS; Abd El-All AS; Ali MM; El-Rashedy AA; El-Desoky AH
    Z Naturforsch C J Biosci; 2018 Nov; 73(11-12):465-478. PubMed ID: 30205654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, spectral characterization, thermal, DFT studies and anticancer cell line activities of Co(II), Ni(II) and Cu(II) complexes of Schiff bases derived from 4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol.
    Tyagi P; Chandra S; Saraswat BS; Yadav D
    Spectrochim Acta A Mol Biomol Spectrosc; 2015 Jun; 145():155-164. PubMed ID: 25770965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New benzimidazoles and their antitumor effects with Aurora A kinase and KSP inhibitory activities.
    Abd El-All AS; Magd-El-Din AA; Ragab FA; ElHefnawi M; Abdalla MM; Galal SA; El-Rashedy AA
    Arch Pharm (Weinheim); 2015 Jul; 348(7):475-86. PubMed ID: 25900113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, spectroscopic characterization and antiproliferative evaluation in vitro of novel Schiff bases related to benzimidazoles.
    Hranjec M; Starčević K; Pavelić SK; Lučin P; Pavelić K; Karminski Zamola G
    Eur J Med Chem; 2011 Jun; 46(6):2274-9. PubMed ID: 21439689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, spectral, antitumor, antioxidant and antimicrobial studies on Cu(II), Ni(II) and Co(II) complexes of 4-[(1H-Benzoimidazol-2-ylimino)-methyl]-benzene-1,3-diol.
    El-wakiel N; El-keiy M; Gaber M
    Spectrochim Acta A Mol Biomol Spectrosc; 2015 Aug; 147():117-23. PubMed ID: 25827773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxicity, Docking Study of New Fluorinated Fused Pyrimidine Scaffold: Thermal and Microwave Irradiation Synthesis.
    Alnaja AMA; Farghaly TA; El-Zahabi HSA; Shaaban MR
    Med Chem; 2021; 17(5):501-518. PubMed ID: 31840613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of N-(2-phenyl-1H-benzo[d]imidazol-5-yl)quinolin-4-amine derivatives as novel VEGFR-2 kinase inhibitors.
    Shi L; Wu TT; Wang Z; Xue JY; Xu YG
    Eur J Med Chem; 2014 Sep; 84():698-707. PubMed ID: 25064347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, characterization of 1,2,4-triazole Schiff base derived 3d-metal complexes: Induces cytotoxicity in HepG2, MCF-7 cell line, BSA binding fluorescence and DFT study.
    Tyagi P; Tyagi M; Agrawal S; Chandra S; Ojha H; Pathak M
    Spectrochim Acta A Mol Biomol Spectrosc; 2017 Jan; 171():246-257. PubMed ID: 27541797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.
    Abdullaziz MA; Abdel-Mohsen HT; El Kerdawy AM; Ragab FAF; Ali MM; Abu-Bakr SM; Girgis AS; El Diwani HI
    Eur J Med Chem; 2017 Aug; 136():315-329. PubMed ID: 28505536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Part I: Design, synthesis and biological evaluation of novel pyrazole-benzimidazole conjugates as checkpoint kinase 2 (Chk2) inhibitors with studying their activities alone and in combination with genotoxic drugs.
    Galal SA; Abdelsamie AS; Shouman SA; Attia YM; Ali HI; Tabll A; El-Shenawy R; El Abd YS; Ali MM; Mahmoud AE; Abdel-Halim AH; Fyiad AA; Girgis AS; El-Diwani HI
    Eur J Med Chem; 2017 Jul; 134():392-405. PubMed ID: 28433679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploiting the biological efficacy of benzimidazole based Schiff base complexes with l-Histidine as a co-ligand: Combined molecular docking, DNA interaction, antimicrobial and cytotoxic studies.
    Kumaravel G; Ponya Utthra P; Raman N
    Bioorg Chem; 2018 Apr; 77():269-279. PubMed ID: 29421702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, biological evaluation of 6-(2-amino-1H-benzo[d]imidazole-6-yl)quinazolin-4(3H)-one derivatives as novel anticancer agents with Aurora kinase inhibition.
    Fan C; Zhong T; Yang H; Yang Y; Wang D; Yang X; Xu Y; Fan Y
    Eur J Med Chem; 2020 Mar; 190():112108. PubMed ID: 32058239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antiproliferative activity in vitro of 2-aminobenzimidazole derivatives.
    Nawrocka W; Sztuba B; Kowalska MW; Liszkiewicz H; Wietrzyk J; Nasulewicz A; Pełczyńska M; Opolski A
    Farmaco; 2004 Feb; 59(2):83-91. PubMed ID: 14871499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of novel polybrominated benzimidazole derivatives-potential CK2 inhibitors with anticancer and proapoptotic activity.
    Łukowska-Chojnacka E; Wińska P; Wielechowska M; Poprzeczko M; Bretner M
    Bioorg Med Chem; 2016 Feb; 24(4):735-41. PubMed ID: 26778657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, spectroscopic, thermal and molecular modeling studies of Zn
    Gaber M; El-Ghamry HA; Fathalla SK; Mansour MA
    Mater Sci Eng C Mater Biol Appl; 2018 Feb; 83():78-89. PubMed ID: 29208290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and docking studies of benzimidazole derivatives as potential EGFR inhibitors.
    Celik İ; Ayhan-Kılcıgil G; Guven B; Kara Z; Gurkan-Alp AS; Karayel A; Onay-Besikci A
    Eur J Med Chem; 2019 Jul; 173():240-249. PubMed ID: 31009910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of novel benzimidazole amidines as potent multi-target inhibitors for the treatment of non-small cell lung cancer.
    Bistrović A; Krstulović L; Harej A; Grbčić P; Sedić M; Koštrun S; Pavelić SK; Bajić M; Raić-Malić S
    Eur J Med Chem; 2018 Jan; 143():1616-1634. PubMed ID: 29133046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of stable benzimidazole derivatives bearing pyrazole as anticancer and EGFR receptor inhibitors.
    Akhtar MJ; Khan AA; Ali Z; Dewangan RP; Rafi M; Hassan MQ; Akhtar MS; Siddiqui AA; Partap S; Pasha S; Yar MS
    Bioorg Chem; 2018 Aug; 78():158-169. PubMed ID: 29571113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on some metal complexes of quinoxaline based unsymmetric ligand: Synthesis, spectral characterization, in vitro biological and molecular modeling studies.
    Dhanaraj CJ; Johnson J
    J Photochem Photobiol B; 2016 Aug; 161():108-21. PubMed ID: 27236046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzimidazole-Based Quinazolines: In Vitro Evaluation, Quantitative Structure-Activity Relationship, and Molecular Modeling as Aurora Kinase Inhibitors.
    Sharma A; Luxami V; Saxena S; Paul K
    Arch Pharm (Weinheim); 2016 Mar; 349(3):193-201. PubMed ID: 26773437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.